Obesity, Dyslipidemia, Diabetes, and Vitamin D Levels

Context: There are several studies that refer to an association between vitamin D levels and the prevalence of atherogenic dyslipidemia and diabetes 2, however these studies present different non-conclusive results. Methods: A cross-sectional study was carried out with a propositional sequential sample of 110 patients at Rio and San Juan Hospital Riobamba -Ecuador 2020. The sample was divided into three groups according to BMI and vitamin D levels; 25 hydroxycalciferol, by cluster analysis, the final groups G1(56), G2(59), and G3(16) had a similar BMI average of 27 kg/m2, and significant differences in the average of vitamin D: G1 = 13.6, G2 = 24.5 and G3 = 45.3 ng/dl. Results: The prevalence of dyslipidemia increased gradually as the average level of vitamin D of the group increased as follows: G1 = 12.5%, G2 = 18.6%, G3 = 18.8%, the same behavior was observed in the prevalence of type 2 diabetes per analysis group: G1 = 30.4%, G2 = 45.8% and G3 = 50%. The differences found in the prevalence of atherogenic dyslipidemia and diabetes 2 were not statistically significant p> 0.05. Conclusion: in the group of patients studied and divided by cluster analysis into three groups with different levels of vitamin D, there were no statistically significant differences with respect to the prevalence of atherogenic dyslipidemia and diabetes 2.